INTRODUCTION
Idiopathic myelofibrosis (IM), also known as agnogenic myeloid metaplasia, is a myeloproliferative disorder of clonal origin of unknown etiopathology characterized by fibrotic degeneration of the marrow and extensive extramedullary hemopoiesis in the spleen For personal use only. on September 24, 2017 . by guest www.bloodjournal.org From and liver (1) (2) (3) . The fact that human IM is often associated with alterations of megakaryocytopoiesis, such as thrombocytopenia and accumulation of megakaryocytes (Mk) in the tissues (1) (2) (3) , has prompted the hypothesis that the disease may be the consequence of chronic activation of bone marrow stromal cells by growth factors, such as TGF-1, PDGF, VEGF and FGF-A, released by Mk in the microenvironment (4, 5) . In mice, the number of Mk in the marrow can be altered by manipulating the in vivo levels of thrombopoietin (TPO), the growth factor which specifically regulates megakaryocytopoiesis (6) . Mice expressing high levels of human TPO, either because transgenic for the human gene (7) or because transplanted with bone marrow cells infected with a retrovirus containing human TPO (8) , express high levels of marrow Mk and blood platelet counts. Both animal models rapidly develop IM (within 2-3 months) (9-11) further supporting the hypothesis for the involvement of Mk in the etiopathology of the human disease. However, in the 14 cases of human IM analyzed so far, the high number of Mk in the marrow was not associated with autocrine TPO production or with mutations in the gene for the TPO receptor (Mpl) (12) . This observation indicates that, unlike the experimentally-induced murine disease, human IM might not be the consequence of alterations in the TPO/Mpl pathway leaving the cause for the increased numbers of Mk observed in these patients still to be ascertained.
GATA-1 is a transcription factor which exerts a well established role in erythroid and megakaryocytic cell differentiation (13) . Definitive proof for its importance in hemopoiesis came from genetic manipulation of the expression of GATA-1 in mice. In fact, mice expressing ectopic levels of the gene show an increased rate of erythroid differentiation (14) while those lacking the gene by targeted mutation die in utero as the consequence of severe anemia (15, 16) . Instrumental to determining the role of GATA-1 in megakaryocytopoesis has been the generation of mutant mice with reduced GATA-1 expression (17, 18) . These mice For personal use only. on September 24, 2017 . by guest www.bloodjournal.org From are anemic but, unlike the deletion mutants, survive for longer periods during gestation up to the stage when alterations in megakaryocytopoiesis are detectable. One of these mutants, the mutant in which the first enhancer (DNA hypersensitive site I) has been replaced with a neo cassette and which lacks the distal GATA-1 promoter (neo HS mouse or GATA-1 low mutant), is born both thrombocytopenic (18, 19) and anemic (20) . The few animals that survive adulthood recover from their anemia at 3-4 weeks of age but remain thrombocytopenic all thei r life (21 and this manuscript) because of a block in the maturation of Mk into proplatelets which results in the accumulation of Mk in the marrow and spleen (18, 21) . The GATA-1 low adult mice can be, therefore, considered as a model to study the effects of chronic increases in the Mk population within tissues in the absence of alterations in the TPO/Mpl signalling pathways.
To further confirm the hypothesis that development of IM may result from accumulation of Mk in the hemopoietic tissues, it was investigated whether the GATA-1 low mice would develop the disease with age. Indeed, early IM traits (presence of reticulinic fibers in the marrow and spleen) could be detected since 10 months of age. However, a frank IM picture (anemia, occurrence of tear drop poikilocytes and progenitor cells in the blood, fibrotic degeneration of the marrow and spleen and active hemopoiesis in the liver) developed only after 15 months. These results indicate that Mk accumulation in the marrow, as consequence of impaired GATA-1 expression, may contribute to the pathogenesis of IM.
MATERIALS AND METHODS
Mice. The GATA-1 low colony (21) was bred according to standard genetic protocols at the animal facilities of the Istituto Superiore di Sanità starting from two genetically modified
For personal use only. on September 24, 2017 . by guest www.bloodjournal.org From animals (17) (one female and one male) kindly provided for this study by Dr. S. Orkin. The original neo HS couple (of mixed C57BL/6-SV 129 background) generated a single male offspring that was crossed with a CD1 female (Charles River, Calco, Italy). Their female offspring was back-crossed with the father until a line of homozygous mutant mice (of mixed C57BL/6-SV 129/CD1 background) was obtained. All of the littermates were genotyped by PCR at birth for the absence of the deleted GATA-1 sequence. Littermates whose genotype contained the GATA-1 region were considered as wild type and used as negative controls.
Other mice used in this study were represented by WBB6F1-W/W v (W/W v ) female mice, purchased at 6 weeks of age from Jackson Laboratory (Bar Harbor, ME, USA). All the animals were housed for up to 2 years in the animal facilities of the Istituto Superiore di Sanità under humane conditions. All the experiments were performed with sex-and agematched mice under protocols approved by the institutional animal care committee.
Hematological blood parameters. Blood was collected from the retro-orbital plexus into ethylen-diamino-tetracetic acid (EDTA)-coated microcapillary tubes µL/sampling). Hematocrit (Hct), white cell and platelet counts were determined manually.
Differential counts of white blood cells were performed on May-Grumwald-Giemsa stained slides, counting at least 100 cells.
Immuno-histochemical analysis. Samples of liver, spleen and bone marrow were routinely fixed in 10% (v/v) phosphate-buffered formalin; bones were decalcified using standard techniques with acidified EDTA. Fixed tissues were paraffin embedded and 2.5-3 µM sections were prepared for hematoxilin-eosin staining or Gomori's reticulum staining (22) . For the search of extramedullary foci of hematopoiesis, liver, lung, and kidney samples were serially cut at 100 µM intervals and at least 25 sections/organ/mouse were examined and their sequence numbered. Immunohistochemical staining with a rat monoclonal antibody
For personal use only. on September 24, 2017 . by guest www.bloodjournal.org From directed against murine CD45 (Ly-5; Pharmingen, San Diego, CA, USA) was performed on numbered livers sections immediately preceeding or following those stained with hematoxilin-eosin in which foci of extramedullary hematopoiesis had been discovered.
CD45-positive cells were identified with the avidin-biotinylated horseradish peroxidase system (ABC Staining system; Santa Cruz Biotechnology Inc, Santa Cruz, CA) using diaminobenzidine (DAB) as a substrate.
Progenitor cell counts. The frequency of progenitor cells (colony-forming unit, erythroid, CFU-E; burst-forming unit, erythroid, BFU-E; colony-forming unit, granulomacrophagic, CFU-GM; pure (p) or mixed (m) colony forming unit, megakaryocytic, CFUMkp and CFU-Mkm) was analyzed by culturing hight density mononuclear cells (0.25-1.0x10 5 cells/plate) of selected organs (marrow, spleen, liver) from wild-type and mutant littermates under specific culture conditions. In the case of peripheral blood, 10 µL of whole blood were directly plated per mL of culture as described (23) . Briefly, cultures were established in standard methylcellulose culture (0.9% w/v) in the presence of fetal bovine serum (FBS, 30% v/v, Hyclone, Logan, Utah, USA) and of a combination of recombinant growth factors including rat stem cell factor (SCF, 100 ng/mL Amgen, Thousand Oaks, CA; USA), mouse interleukin 3 (IL-3, 10 ng/mL; Genetic Institute, Cambridge, MA, USA) and either human erythropoietin (EPO, 2 U/mL; Boehringer Mannheim, Mannheim, Germany) for BFU-E growth or human granulocyte-colony stimulating factor (G-CSF, 50 ng/mL; Neupogen, Dompè Biotech, Milan, Italy) and murine granulocyte-macrophage colony stimulating factor (GM-CSF, 50 ng/mL; a gift of Dr. K. Kaushansky) for CFU-GM growth (24) . The growth of CFU-E-derived colonies was stimulated with EPO alone (2 U/mL) (25) .
The growth of CFU-Mk-derived colonies was obtained in collagen-supplemented cultures (MegaCult TM -C; Stem Cell Technologies, Vancouver, BC, Canada) stimulated with the For personal use only. on September 24, 2017 . by guest www.bloodjournal.org From combination of recombinat cytokines including murine IL-3 (25 ng/mL), IL-6 (100 ng/mL; Sigma), IL-11 (50 ng/mL; Sigma) and human TPO (50 ng/mL; Amgen). The cultures were incubated at 37°C in a humidified incubator containing 5% CO 2 in air and scored after 3 days (for CFU-E-derived colonies) or 7 days (for CFU-GM-, and BFU-E-derived colonies) of culture under an inverted microscope according to standard morphological criteria.
Megakaryocytic colonies and isolated megakaryocytes were counted at day 7 on dehydrated and acetone-fixed collagen cultures stained for acethylcolinesterase (AChE) for 6 hrs, followed by methyl-green nuclear counter-staining, as described (26 antibody as described (27) . Cells incubated with the corresponding irrelevant isotype-matched antibodies were used for gating non-specific fluorescence, and dead cells were excluded by propidium iodide staining (5 µg/mL) (Sigma St Louis, Mo, USA). Megakaryocytes were purified from the spleen as described (27 
RESULTS
Changes in the hematological parameters of GATA-1 low mice with age.
The blood values in progressively older GATA-1 low and wilde-type littermates are summarized in Table II . The mice were divided into three age groups (4-8, 8-12 and 15-20 For personal use only. on September 24, 2017. by guest www.bloodjournal.org From months of age) for convenience. In the normal littermates, small but not statistically significant variations in the blood cell counts occurred during the aging of the animals (Table   II) (Table II) . No variations were observed during aging of the mutant mice in terms of platelet counts that remained significantly lower than normal all through life-span (Table II) . The morphology of the circulating platelets remained also abnormally large and dysplastic ( Figure 1 ).
Figure 1
In the blood of the wild type animals, the number of circulating progenitor cells did not significantly change with age remaining at the lower limit of detection in all the experimental groups (<10 CFC/10 µL, Table III ). In contrast, the number of progenitor cells (of all types) circulating in the blood from the GATA-1 low mice increased by 2-10 fold at 8-12
months and remained higher than normal in older mice (15-20 months) . The bigger changes were observed for the CFU-E, detected at all ages in the blood from the mutants, that reached a peak concentration as high as 114±13 CFU-E per 10 µL of blood at 8-12 months of age (Table III) .
Development of myelofibrosis in the GATA-1 low mice with age.
The myelofibrotic degeneration of the marrow and spleen of the GATA-1 low mice with age is documented in Figure 2 and 3, respectively.
Hematoxilin-eosin examination of bone marrow sections from 1 month-old mutant shows the great prevalence of Mk in the marrow without any sign of alterations detectable in the intracellular space by Gomori's staining ( Figure 2A ). As shown by FACS analysis ( Figure   2D ), the marrow of 1-month old GATA-1 low animals contains 7-times more Mk cells than the marrow from their normal littermates (8.6 vs 1.3%, respectively).
Starting from 12 months of age, there was a progressive reduction of the space available in the marrow for hemopoietic cells due to the simultaneous increase of bone trabeculae and of intercellular matrix. The massive presence of newly-formed bone trabeculae in the femural cavity led, by 18 months, to a decrease in the space available for hemopoietic cells (see the hematoxilin-eosin staining in the left panels of Figure 2A ). In the oldest mice, the increased osteogenesis eventually occluded the femural cavity as evident in the crosssections of the femur diaphysis that show the thickness of the cortical region with the interconnecting bone trabeculae occluding the lumen ( Figure 2B ). The progressive accumulation of fibers in the intercellular space of the marrow from the GATA-1 low mutants was also documented by Gomori's silver staining ( Figure 2A , right panels). The fibers changed from fine and diffuse reticulin fibers at 6-months of age to gross collagen fibers from 12 months on and ultimately filled almost completely the femural cavity.
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The reduction of the space available in the marrow for hemopoietic cells was associated with a reduction in total marrow cellularity ( Figure 2C ). While the cellularity of the marrow from the wild-type mice increased with age, that of the mutant animals, that was slightly but significantly lower than normal already in the 4-8 months age group, was further reduced by 2-fold in the 15-20 months-old group.
Figure 2 A
Figure 2 B,C
Changes were specifically observed in the frequency of progenitor cells in the marrow from the GATA-1 low mice with age. In fact, while no consistent change was found to be associated with age in normal mice, a significant (2-3-fold) decrease was observed in the frequency of all types of progenitor cells in the GATA-1 low mice with age (Table III) which, if adjusted for the reduction in total marrow cellularity, correspond to a 4-fold reduction in total number of progenitor cells per femur.
For Figure 2D The accumulation of reticulin fibers with age was also documented by Gomori's staining in the GATA-1 low spleen ( Figure 3A) . Additional proof for the fibrotic degeneration of this organ came from the fact that the size of the already massive spleen of the mutant mice further increased with age ( Figure 3B ) but the total spleen cellularity -although remaining significantly higher than that of the spleen from the normal mice -decreased with age ( Figure   3C ). Therefore, the increase in spleen weight observed in the GATA-1 low mice at 15-20 months of age was due to accumulation of collagen fibers (Figure 3 ). The total number of cells in the spleen was found to be reduced for the first time at 8-12 months of age when the highest number of CFU-E was present in the circulation ( Figure 3 and Table III) .
No changes were observed in the frequency of progenitor cells in the spleen of the wild-type littermates with age (Table III) The liver as site of extramedullary hematopoiesis in the old Gata-1 low mice.
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As expected, the hematoxylin-eosin staining of fetal liver shows a hemopoietic organ with abundant Mk in its parenchyma ( Figure 4A ) but no sign of active hemopoiesis was detectable in the liver of the GATA-1 low mice after birth (1-12 months of age) ( Figure 4A and results not shown). However, by 18 months, foci of hematopoiesis were recognized again within the liver parenchyma of the mutant animals as confirmed by CD45-immuno-staining of the consecutive liver section (insert in the right panel of Figure 4A ). These foci were never found in liver sections obtained from age-matched wild-type mice (results not shown). Using RNA prepared from the entire femur of wild-type animals, cDNA fragments specific for TGF-, PDGF, and VEGF were amplified at detectable levels only at the highest PCR cycles ( Figure 5A ). On the other end, cDNA fragments for osteocalcin were never amplified even when the reaction was extended up to 40 cycles ( Figure 5A and results not shown). These results confirm that these genes are expressed at low levels by preparations of unfractionated bone and marrow cells from adult wild-type mice. In contrast, with RNA prepared from GATA-1 low femurs, cDNA fragments for osteocalcin were readily amplified
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From and amplification of cDNA fragments for TGF-, PDGF, and VEGF was detectable even after few cycles ( Figure 5A ). These results indicate that all these genes are expressed at higher levels in the femur of the mutant mice than in that of the normal ones. Since fragments for FGF-A were barely amplified at the highest PCR cycles using RNA from both normal and GATA-1 low femurs, it is not possible to draw any conclusion on its relative levels of expression in the GATA-1 low vs the wild-type femur. Survival of the GATA-1 low mice with age.
The Kaplan-Meier analysis of the probability of survival of the GATA-1 low mice with age is shown in Figure 6 . Mice sacrificed for experimental purposes were censored from the analysis. It is difficult to calculate the percent of survival of the GATA-1 low mice at birth because only 30% of the pregnancies induced (as established by the presence of the vaginal plug 24-48 hrs after mating) resulted in viable pups. Once the pups were born, however, they were highly vital since only 9, out of 178 GATA-1 low mutants born alive, died within the first 15 days of life ( Figure 6 ). Very few (6) mice died from 15-days to 13-month of age. The majority of the deaths (10 over a total of 25 natural death recorded) occured between 14 th and 20 th months of age with only 9 animals alive after 20-months. Since normal littermates in numbers sufficient for survival studies were not available, the probability for survival of the (Table II) , tear drop poikilocytes ( Figure 1 ) and progenitor cells (Table III) IM is a clonal disease that can be experimentally transmitted in mice (10) and cured in mice (9) and men (42) by bone marrow transplantation and which is associated with Mk accumulation in the marrow and thrombocytopenia as well as anemia in the blood. These facts suggest that IM may be caused by gene defects that impair the stem cell ability to differentiate along both the Mk and the erythroid pathway. TPO and its receptor, Mpl, the two genes most likely to cause defective Mk differentiation (6), have not been found altered in 14 IM patients carefully analyzed for this purpose (12) . Therefore the search for the genetic defect involved in the development of IM is still open. On the basis of 1) the fact that IM, as the human genetic diseases associated with GATA-1 mutations described so far (38 -41), presents defective differentiation both of the megakaryocytic and the erythroid pathway, 2)
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From the slightly higher incidence of IM in males that in females [0.73 and 0.40 new diagnoses every year per 100,000 males and females, respectively (43) which indicate that its cause may be partially X-linked] and 3) the phenotype of the GATA-1 low mice described in this paper, we suggest that, at least in some of the cases, human IM may result from altered regulation of GATA-1 gene expression and/or from other mutations in the GATA-1 functional pathway.
Current experiments are underway to verify this hypothesis.
Several animal models have been developed in the recent years for the study of IM.
The major difference found between the IM traits expressed by the GATA-1 low mice and those expressed by other models for the disease is represented by the rate of the progression toward its final exitus that was slow in the GATA-1 low mice but very rapid in the other models. In fact, wild-type mice transplanted with bone marrow cells infected with a TPOcontaining retrovirus develop a fatal IM syndrome within 2.5-3 months and the final exitus was recorded approximately seven months from the transplant (9, 10). Furthermore, mice transgenic for the TPO gene survive only shortly after birth (7). In contrast, the GATA-1 low mice manifested their first IM simptoms, i.e., reticulin fibers in the marrow and in the spleen (Figure 2 and 3) and alterations in the frequencies of progenitor cells in the various organs (Table III and Figure 4 ), at 8-12 months of age while a clear picture of IM was not observed until 15 months (Figure 1, 2 and 3) . However, very few of the GATA-1 low mice survived more than 2-4 months after the first sign of the disease had became manifested ( Figure 6 ).
The slow appearance of the first IM traits followed by a rapid final exitus has strong analogies with the human disease. In fact, human IM is usually diagnosed in the second half of life but, when the first sign of the disease became manifested, the final exitus occurs within 4.5 years (3). In contrast with human IM that may evolve into acute leukemia, leukemic cells and growth factor independent hemopoietic progenitors were never detect in tissues from GATA- experiments per age group. In particular, a total of 12 mice were analyzed for the 12-18 months old age-group.
B. Weight (in mg) of the spleen from wild-type (white bars) and GATA-1 low (grey bars) littermates arbitrarily divided into progressively older age groups (the same as used in Table II) . The results are presented as the mean (±SD) of at least 4 The results are presented as number of colonies per 10 5 mononuclear cells (either from marrow or spleen) and per 10µL of peripheral Blood. Mean (±SD) of at least 3 separate experiments performed in duplicate for a total of 3-5 mutants and 3 normal littermates analyzed per each age group. Values in the GATA-1 low mice statistically different from those observed in the corresponding wild-type animals are indicated by * (p<0.05) and ** (p>0.01). Individual progenitor cells are indicates as: colony-forming unit, erythroid, CFU-E; burstforming unit, erythroid, BFU-E; colony-forming unit, granulo-macrophagic, CFU-GM; pure (p) or mixed (m) colony forming unit, megakaryocytic, CFU-Mkp and CFU-Mkm. 
